Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies

Human monoclonal antibodies (mAbs) that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been isolated from convalescent individuals and developed into therapeutics for SARS-CoV-2 infection. However, therapeutic mAbs for SARS-CoV-2 have been rendered obsolet...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fengwen, Jenkins, Jesse, de Carvalho, Renan V. H., Nakandakari-Higa, Sandra, Chen, Teresia, Abernathy, Morgan E., Baharani, Viren A., Nyakatura, Elisabeth K., Andrew, David, Lebedeva, Irina V., Lorenz, Ivo C., Hoffmann, H.-Heinrich, Rice, Charles M., Victora, Gabriel D., Barnes, Christopher O., Hatziioannou, Theodora, Bieniasz, Paul D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234812/
https://www.ncbi.nlm.nih.gov/pubmed/37188812
http://dx.doi.org/10.1038/s41564-023-01389-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234812/
https://www.ncbi.nlm.nih.gov/pubmed/37188812
http://dx.doi.org/10.1038/s41564-023-01389-9

Ejemplares similares